
According to data from Benzinga Pro, during Q1, Ultralife's (NASDAQ:ULBI) reported sales totaled $30.37 million. Despite a 85.73% increase in earnings, the company posted a loss of $161.00 thousand. Ultralife collected $23.76 million in revenue during Q4, but reported earnings showed a $1.13 million loss.